Brief: Edwards Lifesciences Q2 Adjusted EPS USD 0.67 Vs. IBES Estimate USD 0.62
24/07/2025 21:15
Jul 24 (Reuters) - Edwards Lifesciences Q2 sales USD 1,532.2 million vs. IBES estimate USD 1,489 million. Q2 gross profit USD 1,187.8 million Q2 net income USD 331.5 million Q2 EPS USD 0.56 outlook Q3 adjusted EPS USD 0.54-0.6 outlook Q3 sales USD 1,460-1,540 million
Recent news on Edwards Lifesciences
See all newsFDA flags Edwards heart-valve delivery system issue after death, injury (updated)
FDA flags Edwards heart-valve delivery system issue after death, injury
Brief: FDA Aware Edwards Lifesciences Issued Letter Recommending Some Delivery Systems Used For Sapien M3 Transcatheter Mitral Valve Replacement Be Removed
Brief: Edwards Lifesciences Corporation - Maintains Confidence In Financial Guidance For 2026
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals